Skip to main content
Fig. 7 | Microbial Cell Factories

Fig. 7

From: Anti-cancer and anti-inflammatory effects elicited by short chain fatty acids produced by Escherichia coli isolated from healthy human gut microbiota

Fig. 7

Effects of E. coli KUB-36 metabolites and its individual SCFA on inflammatory cytokine gene expressions of LPS stimulated THP-1 macrophage cells. a Inflammatory cytokine IL-1β expression. b Inflammatory cytokine IL-6 expression. c Inflammatory cytokine IL-8 expression and d inflammatory cytokine TNF-α expression. IC50 values of E. coli KUB-36 metabolites and its individual SCFA were used in this experiment [E. coli metabolite; IC50 = 68.90%, Acetic acid; IC50 = 51.30% (12.26 mM); Butyric acid; IC50 = 59.88% (1.80 mM); Isobutyric acid; IC50 = 67.07% (1.13 mM); Propionic acid; IC50 = 63.63% (1.37 mM); Valeric acid; IC50 = 60.08% (1.70 mM); Isovaleric acid; IC50 = 58.27% (1.62 mM); Caproic acid; IC50 = 61.56% (2.23 mM)]. THP-1 macrophages cells were treated with E. coli KUB-36 metabolites and its individual SCFA for 3 h before exposure to LPS for 6 h. Inflammatory cytokine gene expression was expressed relative to THP-1 macrophages cells stimulated by control LPS, which was calculated by 2−ΔΔCt method. Data are plotted as average values of relative fold change ± standard error. Different lowercase superscript letters (a–d) shown in the column indicate significant differences (p < 0.05) between mean scores of each column from 6 replicates

Back to article page